|
Resolution: standard / high Figure 1.
Flow chart of study selection. ADA = American Diabetes Association, DAHTA = Deutsche Agentur für Health Technology
Assessment, DARE = National Health Service's Database of Abstracts of Reviews of Effects,
DDG = Deutsche Diabetes Gesellschaft, EASD = European Association for the Study of
Diabetes, GLA = Insulin glargine, GMS = German Medical Science, ISPOR = International
Society for Pharmacoeconomics and Outcomes Research, NHS-EED = National Health Service
Economic Evaluation Database, NHS-HTA = National Health Service Health Technology
Assessment Database, NPH = Neutral Protamine Hagedorn insulin.
Hagenmeyer et al. Cost Effectiveness and Resource Allocation 2011 9:15 doi:10.1186/1478-7547-9-15 |